NHS urged to prioritise cancer care basics over tech and AI ‘magic bullets’ | Health service is at tipping point, say experts, and ‘novel solutions’ have been wrongly hyped

Read Full Article

#NHS #cancer #healthcare #technology #AI

Endometriosis needs to be treated by NHS as chronic condition, experts say | Study finds condition is often not seen as continuum of symptoms and needs to be taken as seriously as diabetes

Read Full Article

#endometriosis #NHS #chroniccondition #womenshealth #awareness

11% of 1710 patients (190 people) who took part in NHS England’s Type 2 Diabetes Path to Remission programme, which involves a three month “soups and shakes” diet, went into remission

Read Full Article

#NHS #Type2Diabetes #RemissionProgramme #HealthJourney #DiabetesAwareness

📉 A King's College London study using data from over 29 million people in England reveals major conditions like depression are still diagnosed at lower rates than before the pandemic. Depression diagnoses are down 27.7%, asthma by 16.4%, COPD by 15.8%, and osteoporosis by 11.5%.

⚖️ Recovery in diagnosis rates varies by group. Dementia diagnoses have returned to pre-pandemic levels for white individuals and those in less deprived areas, but remain lower for other ethnic groups and more deprived communities.

🧠 Depression diagnoses are particularly concerning, showing a decline since 2022, especially among younger adults (20-39) and those of white or mixed ethnicity. This contrasts with rising mental health disability claims, suggesting diagnosis rates don't reflect mental health improvement.

📈 Chronic Kidney Disease (CKD) diagnoses have surprisingly increased by 34.8%, potentially due to more testing, guideline changes, and new treatments, or even COVID-19's impact.

#Health #COVID19 #NHS

💡 A new study published in BMJ Mental Health on Wednesday, 28 January 2026, suggests Transcranial Magnetic Stimulation (TMS) is a cost-effective treatment for moderate to severe depression resistant to other therapies. The analysis, led by Edward Cox and Professor Richard Morriss, indicates TMS can reduce depressive symptoms, ease burdens on informal carers and NHS resources, and help individuals return to work.

💰 The economic analysis found TMS to be a valuable investment for the NHS, with costs recovered over time through savings in the wider health service and reduced lost workdays. The study compared TMS (rTMS and iTBS) to usual care, showing it can provide faster and more sustained improvements for patients with treatment-resistant depression.

📈 TMS is an outpatient procedure involving magnetic pulses to the brain. Despite being invented in the UK and approved by NICE in 2015, its availability in NHS Trusts is limited, partly due to a lack of clear economic evidence. This new research provides that evidence, suggesting TMS is cost-effective and even cost-saving when including health, informal care, and work productivity benefits.

#MentalHealth #NHS #Depression

* 🚫 NHS England has banned new hormone prescriptions for transgender youth under 18, citing "low quality" evidence from 10 reviews that excluded 97% of studies.

* 🔬 The reviews used a method of "salami slicing" by creating artificially narrow categories, leading to the exclusion of significant studies like the Chen et al 2023 NIH-funded study and the Dutch Protocol research.

* 📉 Even surviving studies showing benefits were rated "very low certainty" using the GRADE system, a framework developer Gordon Guyatt has called "egregious and unconscionable" when used to justify bans.

#TransHealth #GenderAffirmingCare #NHS

(⚠️ Formatting disabled due to Markdown error)

🩸 First papers from the large-scale NHS cancer blood test trial, involving 142,000 volunteers aged 50–77, have been published in leading journals, assessing the Galleri® multi-cancer early detection (MCED) test.

📄 One paper in the New England Journal of Medicine shows fewer people diagnosed with stage 4 cancers in the test group, with more early-stage diagnoses and fewer emergency diagnoses, but no overall difference in late-stage cancers (stages 3 & 4 combined) compared to the control group.

🔬 The second paper in Nature Medicine reports the Galleri® test's accuracy: around one-third of cancer patients received a positive signal, while less than 0.5% of those without cancer had a false positive result.

#CancerResearch #NHS #EarlyDetection